< Back to latest news & events

News

Gender diversity at the UPC

November 2022

In Europe, women remain grossly under-represented in research and innovation. A recent study by the European Patent Office (EPO) found that only 13.2% of inventors in Europe are women.

The Unified Patent Court (UPC) is a new Court that is being set up to decide in particular on the infringement and validity of both new Unitary Patents and classic European Patents; comprising judges from all participating Member States of the European Union.

The Unified Patent Court has now confirmed the appointment of a total of 85 judges (34 legally qualified judges and 51 technically qualified judges) to take up their duties as of the entry into force of the UPC Agreement. Looking at the composition of the UPC Judiciary, taking the published prefix of Mr and Ms for each Judge as a proxy for men and women we looked the relative proportions of appointments (see table 1). Women are set to make up slightly more than half (16 Mr : 18 Ms) of the Legally Qualified Judges.

However, this is not true for Technically Qualified Judges.

It is widely reported that the percentage of female STEM graduates is considerably lower than male STEM graduates.

Women in Tech reports that:
Around 15% of engineering graduates are female, 38% for Maths, and 19% for Computer Studies. This gap in STEM education translates in the workplace to men dominating the industry with just 19% being women. Encouraging girls to study STEM subjects with the view of pursuing a career in tech is important not just for the campaign for gender equality in society, but also for the UK’s competitiveness as technology pioneers. It has been estimated that by 2025, the UK will be 1.8 million short of engineers. Levelling the playing field and making a career in tech more appealing and exciting in the eyes of future generations is a way to prevent a skills shortage in the future of the UK tech industry.

Although we do not know what proportion of UPC judicial candidates were women, overall, in the UPC as in STEM, it would appear there is still some way to go for women in their technical fields to reach parity with men.

Table 1


This article was prepared by HGF’s Partner & Patent Attorney Hsu Min Chung.

Latest updates

Event - 10th September 2025

Seminar on Incorporating Trade Secrets into your IP Strategy

HGF is hosting a Seminar on Incorporating Trade Secrets into your IP Strategy which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 10th …

Event details

EU Customs Recordals

Read article

HGF Partners Recognised in IAM Strategy 300 2025

The latest edition of IAM Strategy 300: The World’s Leading IP Strategists has now been published, and HGF is proud to announce that three of our partners have been listed …

Read article
Event - 25th September 2025

HGF Futures Life Sciences – Join our open day in London

An opportunity to discover your path to becoming a Life Science Patent Attorney! Are you a recent or soon-to-be graduate with a degree in Life Sciences? Are you passionate about …

Event details

Celebrating exam success at HGF

We would like to congratulate our colleagues on their recent exam success. Their dedication, perseverance, and commitment to professional development have led to success, and we are pleased to celebrate …

Read article
Event - 5th November 2025

IAM Navigating the UPC conference

HGF are gold sponsors of the IAM Live Navigating the UPC conference. The IAM Live Navigating the UPC will take place at the Marriott Opera Ambassador Hotel, Paris on 5th …

Event details

Post Sale Confusion – dupes and lookalikes beware?

Last month, the UK Supreme Court issued its highly-anticipated decision in Iconix Luxembourg Holdings SARL v Dream Pairs Europe Inc and another [2025] UKSC 25. Helpful background to the dispute …

Read article

A leading case - beware sequence errors in patent claims

Samsung Bioepis UK Ltd v Alexion Pharmaceuticals Inc [2025] EWHC 1240 (Pat) – Mr Justice Meade – 20 May 2025 The UK Patents Court has held that Samsung Bioepis’ and Amgen’s …

Read article